Literature DB >> 15030176

The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL.

Steffi Kopprasch1, Jens Pietzsch, Juergen Graessler.   

Abstract

Hypochlorite-oxidized low-density lipoprotein (oxLDL) possesses a substantial proinflammatory potential by modulating respiratory burst activities of polymorphonuclear neutrophils (PMN). As evaluated by luminol-amplified chemiluminescence (CL) incubation of 10(6) PMN/ml with 70 nM oxLDL was followed by substantial induction of neutrophil oxidant (ROS) generation. We evaluated the inhibitory capacity of high-density lipoprotein (HDL) and its lipid and protein constituents against the activating effects of oxLDL. At a HDL or apolipoprotein AI/LDL protein ratio of 1.0, native HDL decreased the respiratory burst activation by 64%, followed by trypsinized HDL (57%) and native apoAI (43%). The inhibitory effects of native HDL did not require prior incubation with PMN or with oxLDL suggesting an instantaneously acting protective mechanism in the minute range. OxLDL modulated ROS production not only of resting PMN but also that of activated PMN, as indicated by a 14-fold increase in FMLP-stimulated CL response and a 50% decrease in zymosan-mediated CL answer. HDL itself did not protect PMN from activation by FMLP and zymosan. However, it clearly reduced effects of oxLDL on FMLP-activation and slightly counteracted the oxLDL-mediated decrease in zymosan-induced ROS generation. Taken together, these findings may offer new insight into atheroprotective mechanisms of HDL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030176     DOI: 10.1023/b:mcbi.0000012842.19059.c5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.

Authors:  Polkit Sangvanich; Bharti Mackness; Simon J Gaskell; Paul Durrington; Michael Mackness
Journal:  Biochem Biophys Res Commun       Date:  2003-01-10       Impact factor: 3.575

2.  In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.

Authors:  Steffi Kopprasch; Jens Pietzsch; Eberhard Kuhlisch; Katja Fuecker; Theodora Temelkova-Kurktschiev; Markolf Hanefeld; Helmut Kühne; Ulrich Julius; Jürgen Graessler
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

3.  Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins.

Authors:  A M Scanu; C Edelstein
Journal:  Anal Biochem       Date:  1971-12       Impact factor: 3.365

4.  Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.

Authors:  B Garner; A R Waldeck; P K Witting; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells.

Authors:  S Kopprasch; W Leonhardt; J Pietzsch; H Kühne
Journal:  Atherosclerosis       Date:  1998-02       Impact factor: 5.162

6.  Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor.

Authors:  J Nilsson; B Dahlgren; M Ares; J Westman; A Hultgårdh Nilsson; B Cercek; P K Shah
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

Review 7.  Immunological responses to oxidized LDL.

Authors:  S Hörkkö; C J Binder; P X Shaw; M K Chang; G Silverman; W Palinski; J L Witztum
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

8.  Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.

Authors:  J Pietzsch; P Lattke; U Julius
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

9.  High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.

Authors:  Y Matsuda; K Hirata; N Inoue; M Suematsu; S Kawashima; H Akita; M Yokoyama
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

10.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

Authors:  J Johansson; L A Carlson; C Landou; A Hamsten
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb
View more
  12 in total

1.  Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.

Authors:  Sarama Saha; Juergen Graessler; Stefan R Bornstein; Peter E H Schwarz; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2013-07-14       Impact factor: 3.396

2.  The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

Authors:  Fatiha Tabet; Alan T Remaley; Aude I Segaliny; Jonathan Millet; Ling Yan; Shirley Nakhla; Philip J Barter; Kerry-Anne Rye; Gilles Lambert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

Review 3.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  Effects of rosiglitazone on native low-density-lipoprotein-induced respiratory burst in circulating monocytes and on the leukocyte-endothelial interaction in cholesterol-fed rats.

Authors:  Long Sheng Lu; Li Man Hung; Chang Hui Liao; Chau Chung Wu; Ming Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-21       Impact factor: 3.000

Review 5.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 6.  The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity.

Authors:  Marisa Fernandes das Neves; Joana R Batuca; José Delgado Alves
Journal:  Immunology       Date:  2021-05-22       Impact factor: 7.215

Review 7.  Synthetic high-density lipoprotein nanoparticles: Good things in small packages.

Authors:  Robert M Lavker; Nihal Kaplan; Kaylin M McMahon; Andrea E Calvert; Stephen E Henrich; Ummiye V Onay; Kurt Q Lu; Han Peng; C Shad Thaxton
Journal:  Ocul Surf       Date:  2021-04-21       Impact factor: 6.268

8.  Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).

Authors:  Sigrun Badrnya; Alice Assinger; Ivo Volf
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

9.  ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation.

Authors:  Margit Keresztes; Tamás Horváth; Imre Ocsovszki; Imre Földesi; Gyöngyi Serfőző; Krisztina Boda; Imre Ungi
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 10.  High-density lipoproteins during sepsis: from bench to bedside.

Authors:  Sébastien Tanaka; David Couret; Alexy Tran-Dinh; Jacques Duranteau; Philippe Montravers; Anna Schwendeman; Olivier Meilhac
Journal:  Crit Care       Date:  2020-04-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.